SAM
AVBP icon

Sectoral Asset Management’s ArriVent BioPharma AVBP Stock Holding History

Sectoral Asset Management’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$720K Sell
30,013
-8,242
-22% -$186K 0.6% 44
2025
Q4 		$770K Sell
38,255
-980
-2% -$20.4K 0.62% 44
2025
Q3 		$724K Buy
39,235
+3,655
+10% +$71.8K 0.45% 59
2025
Q2 		$775K Buy
35,580
+25,490
+253% +$529K 0.51% 51
2025
Q1 		$187K Buy
+10,090
New +$247K 0.15% 73

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sectoral Asset Management's AVBP Position: Q1 2026 in Review

Sectoral Asset Management reduced its ArriVent BioPharma (AVBP) stake by 22% in Q1 2026, selling an estimated $186K and leaving 30,013 shares worth $720K. The position accounts for 0.6% of the portfolio, ranked #44.

Sectoral Asset Management first reported a position in AVBP in Q1 2025 and has held it in 5 quarters since. The position peaked at $775K in Q2 2025. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Sectoral Asset Management held 30,013 shares of ArriVent BioPharma worth $720K as of Q1 2026.
  • Sectoral Asset Management sold 8,242 ArriVent BioPharma shares in Q1 2026, an estimated $186K.
  • ArriVent BioPharma made up 0.6% of Sectoral Asset Management's portfolio in Q1 2026, its #44 holding.
  • Sectoral Asset Management first reported a position in ArriVent BioPharma in Q1 2025 and has held it in 5 quarters since.
  • Sectoral Asset Management's ArriVent BioPharma position peaked at $775K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.